Accéder au contenu
Merck

Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme.

Cell reports (2019-02-21)
Rachel Cliffe, Jason C Sang, Franziska Kundel, Daniel Finley, David Klenerman, Yu Ye
RÉSUMÉ

Filamentous aggregates (fibrils) are regarded as the final stage in the assembly of amyloidogenic proteins and are formed in many neurodegenerative diseases. Accumulation of aggregates occurs as a result of an imbalance between their formation and removal. Here we use single-aggregate imaging to show that large fibrils assembled from full-length tau are substrates of the 26S proteasome holoenzyme, which fragments them into small aggregates. Interestingly, although degradation of monomeric tau is not inhibited by adenosine 5'-(3-thiotriphosphate) (ATPγS), fibril fragmentation is predominantly dependent on the ATPase activity of the proteasome. The proteasome holoenzyme also targets fibrils assembled from α-synuclein, suggesting that its fibril-fragmenting function may be a general mechanism. The fragmented species produced by the proteasome shows significant toxicity to human cell lines compared with intact fibrils. Together, our results indicate that the proteasome holoenzyme possesses a fragmentation function that disassembles large fibrils into smaller and more cytotoxic species.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Geldanamycin Ready Made Solution, 1 mg/mL, from Streptomyces hygroscopicus